Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.